BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 32579550)

  • 41. Factors Associated with Immunological Discordance in HIV-Infected Patients Receiving Antiretroviral Therapy with Complete Viral Suppression in a Resource-Limited Setting.
    Mingbunjerdsuk P; Asdamongkol N; Sungkanuparph S
    Jpn J Infect Dis; 2015; 68(4):301-4. PubMed ID: 25720640
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comprehensive evaluation of the immune risk phenotype in successfully treated HIV-infected individuals.
    Ndumbi P; Gilbert L; Tsoukas CM
    PLoS One; 2015; 10(2):e0117039. PubMed ID: 25647167
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Low CD4 T-cell counts despite low levels of circulating HIV: insights from the comparison of HIV-1 infected patients with a discordant response to antiretroviral therapy to patients with untreated advanced HIV-2 disease.
    Albuquerque AS; Foxall RB; Cortesão CS; Soares RS; Doroana M; Ribeiro A; Lucas M; Antunes F; Victorino RM; Sousa AE
    Clin Immunol; 2007 Oct; 125(1):67-75. PubMed ID: 17692571
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The role of IL-1beta in reduced IL-7 production by stromal and epithelial cells: a model for impaired T-cell numbers in the gut during HIV-1 infection.
    Thang PH; Ruffin N; Brodin D; Rethi B; Cam PD; Hien NT; Lopalco L; Vivar N; Chiodi F
    J Intern Med; 2010 Aug; 268(2):181-93. PubMed ID: 20497296
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Circulating levels of interleukin-7 in antiretroviral-naïve and highly active antiretroviral therapy-treated HIV-infected patients.
    Mastroianni CM; Forcina G; d'Ettorre G; Lichtner M; Mengoni F; D'Agostino C; Vullo V
    HIV Clin Trials; 2001; 2(2):108-12. PubMed ID: 11590518
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Abnormal cytokine production by circulating monocytes and dendritic cells of myeloid origin in ART-treated HIV-1+ patients relates to CD4+ T-cell recovery and HCV co-infection.
    Almeida M; Cordero M; Almeida J; Orfao A
    Curr HIV Res; 2007 May; 5(3):325-36. PubMed ID: 17504174
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Biological determinants of immune reconstitution in HIV-infected patients receiving antiretroviral therapy: the role of interleukin 7 and interleukin 7 receptor α and microbial translocation.
    Rajasuriar R; Booth D; Solomon A; Chua K; Spelman T; Gouillou M; Schlub TE; Davenport M; Crowe S; Elliott J; Hoy J; Fairley C; Stewart G; Cameron P; Lewin SR
    J Infect Dis; 2010 Oct; 202(8):1254-64. PubMed ID: 20812848
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reduced thymic output is a major mechanism of immune reconstitution failure in HIV-infected patients after long-term antiretroviral therapy.
    Li T; Wu N; Dai Y; Qiu Z; Han Y; Xie J; Zhu T; Li Y
    Clin Infect Dis; 2011 Nov; 53(9):944-51. PubMed ID: 21960716
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A Low Frequency of IL-17-Producing CD8
    Perdomo-Celis F; Feria MG; Taborda NA; Rugeles MT
    Front Immunol; 2018; 9():2502. PubMed ID: 30420859
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The NLRP3 Inflammasome Is Upregulated in HIV-Infected Antiretroviral Therapy-Treated Individuals with Defective Immune Recovery.
    Bandera A; Masetti M; Fabbiani M; Biasin M; Muscatello A; Squillace N; Clerici M; Gori A; Trabattoni D
    Front Immunol; 2018; 9():214. PubMed ID: 29483915
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term immunological response in HIV-1-infected subjects receiving potent antiretroviral therapy.
    Kaufmann GR; Bloch M; Zaunders JJ; Smith D; Cooper DA
    AIDS; 2000 May; 14(8):959-69. PubMed ID: 10853977
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of highly active anti-retroviral therapy and hepatitis C virus co-infection on serum levels of pro-inflammatory and immunoregulatory cytokines in human immunodeficiency virus-1-infected individuals.
    Tornero C; Alberola J; Tamarit A; Navarro D
    Clin Microbiol Infect; 2006 Jun; 12(6):555-60. PubMed ID: 16700705
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Influence of polymorphisms within the CX3CR1 and MDR-1 genes on initial antiretroviral therapy response.
    Brumme ZL; Dong WW; Chan KJ; Hogg RS; Montaner JS; O'Shaughnessy MV; Harrigan PR
    AIDS; 2003 Jan; 17(2):201-8. PubMed ID: 12545080
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunological and virological failure after antiretroviral therapy is associated with enhanced peripheral and thymic pathogenicity.
    Solomon A; Cameron PU; Bailey M; Dunne AL; Crowe SM; Hoy JF; Lewin SR
    J Infect Dis; 2003 Jun; 187(12):1915-23. PubMed ID: 12792868
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Responsiveness to IL-7 but not to IFN-α is diminished in CD4+ T cells from treated HIV infected patients who experience poor CD4+ T-cell recovery.
    Nguyen TP; Shukla S; Asaad R; Freeman ML; Lederman MM; Harding CV; Sieg SF
    AIDS; 2016 Aug; 30(13):2033-42. PubMed ID: 27191978
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dysregulated Immune Activation in Second-Line HAART HIV+ Patients Is Similar to That of Untreated Patients.
    Espíndola MS; Lima LJ; Soares LS; Cacemiro MC; Zambuzi FA; de Souza Gomes M; Amaral LR; Bollela VR; Martins-Filho OA; Frantz FG
    PLoS One; 2015; 10(12):e0145261. PubMed ID: 26684789
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Low-dose daily subcutaneous interleukin-2 in combination with highly active antiretroviral therapy in HIV+ patients: a randomized controlled trial.
    Lalezari JP; Beal JA; Ruane PJ; Cohen CJ; Jacobson EL; Sundin D; Leong WP; Raffanti SP; Wheeler DA; Anderson RD; Keiser P; Schrader SR; Goodgame JC; Steinhart CR; Murphy RL; Wolin MJ; Smith KA
    HIV Clin Trials; 2000; 1(3):1-15. PubMed ID: 11590500
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The naive CD4+ count in HIV-1-infected patients at time of initiation of highly active antiretroviral therapy is strongly associated with the level of immunological recovery.
    Michael CG; Kirk O; Mathiesen L; Nielsen SD
    Scand J Infect Dis; 2002; 34(1):45-9. PubMed ID: 11874164
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Failure to reconstitute CD4+ T-cells despite suppression of HIV replication under HAART.
    Aiuti F; Mezzaroma I
    AIDS Rev; 2006; 8(2):88-97. PubMed ID: 16848276
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of drug resistance genotypes on CD4+ counts and plasma viremia in heavily antiretroviral-experienced HIV-infected patients.
    Rodes B; García F; Gutierrez C; Martinez-Picado J; Aguilera A; Saumoy M; Vallejo A; Domingo P; Dalmau D; Ribas MA; Blanco JL; Pedreira J; Perez-Elias MJ; Leal M; de Mendoza C; Soriano V;
    J Med Virol; 2005 Sep; 77(1):23-8. PubMed ID: 16032728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.